![1]()
News
FDA approves Baqsimi nasal powder for emergency hypoglycemia treatment
July 25, 2019
It is the first glucagon therapy approved for this indication that is administrable without an injection.
![1]()
News
FDA issues warning on insulin pump cybersecurity weakness
June 28, 2019
The MiniMed 508 and MiniMed Paradigm series insulin pumps are being recalled because of potential cybersecurity risks; 4,000 patients in the United States are affected.
![1]()
News
Aspirin shows little benefit for primary prevention of vascular disease in diabetes
May 15, 2019
Is aspirin for primary prevention of cardiovascular events in patients with diabetes worth the risk of adverse bleeding events?
![1]()
News
SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF
May 9, 2019
NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart failure,” Dr. Mikhail Kosiborod said.
News
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
March 12, 2019
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
![1]()
News
ICU admissions raise chronic condition risk
February 27, 2019
Compared to non-ICU visitors, patients had greater risk of developing new chronic conditions after discharge.
![1]()
News
SGLT2 inhibitors morph into HF drugs
February 7, 2019
“We’re increasingly moving to an age where these agents are actually cardiovascular drugs that happen to lower blood glucose.” – Dr. Akshay S. Desai
![1]()
News
Intensive insulin added no benefit for hyperglycemia after ischemic stroke
February 7, 2019
Results from a large RCT showed intensive and standard insulin regimens produced similar clinical outcomes after an acute ischemic stroke.
![1]()
News
Metformin associated with acidosis only in patients with eGFR 30 mL/min per 1.73 m 2
January 17, 2019
Does metformin increase the risk of lactic acidosis in chronic kidney disease (CKD)?
![1]()
News
SGLT-2 inhibitors promising for heart failure prevention, not treatment
January 12, 2019
LOS ANGELES – The combination of heart failure and diabetes is particularly lethal.
